Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

R. Büller, Harry; L. Davidson, Bruce; Decousus, Hervé; Gallus, Alexander; Gent, Michael; Piovella, Franco; H. Prins, Martin; Raskob, Gary; E.M. Segers, Annelise; Cariou, Roger; Leeuwenkamp, Oscar; W.A. Lensing, Anthonie; The Matisse Investigators*, and

doi:10.7326/0003-4819-140-11-200406010-00007

Public

Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

Published in Annals of Internal Medicine • Jun 1, 2004

Authors:

Harry R. Büller

Bruce L. Davidson

Hervé Decousus

Abstract

BACKGROUND: The current standard initial therapies for deep venous thrombosis are low-molecular-weight heparin and unfractionated heparin. In a dose-ranging study of patients with symptomatic deep venous thrombosis, fondaparinux had efficacy and a safety profile similar to those of low-molecular-wei...

Subject

Medicine

Fondaparinux

Venous thrombosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!